(Quinoxalin-2-yl)methanamine
CAS: 131052-78-3
Ref. 3D-GFA05278
| 1g | Descatalogado | ||
| 5g | Descatalogado | ||
| 100mg | Descatalogado | ||
| 250mg | Descatalogado | ||
| 500mg | Descatalogado |
Información del producto
Nombre:
(Quinoxalin-2-yl)methanamine
Descripción:
(Quinoxalin-2-yl)methanamine is a potent antagonist of potassium channels that has shown anti-tumor activity in animal models. It inhibits the growth of tumor cells and induces apoptosis through the inhibition of protein synthesis and DNA replication. The anti-tumor effects are likely due to the inhibition of potassium channels, which prevents cell proliferation and induces programmed cell death. (Quinoxalin-2-yl)methanamine is a prodrug that is converted by hydrolysis to its active form, quinoxaline, which has been shown to be effective against arrhythmia in rat hearts.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
159.19 g/mol
Fórmula:
C9H9N3
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
